The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Anti‐neuronal nuclear autoantibody type 2: Paraneoplastic accompaniments
Abstract
We identified the IgG autoantibody ANNA‐2 (“anti‐Ri”) in 34 patients in a 12‐year period by immunofluorescence screening of sera from approximately 75,000 patients with subacute neurological disorders that were suspected to be paraneoplastic. Detailed clinical information was available for 28 patients (10 men, 18 women). Cancer was diagnosed in 24 patients (86%); 21 had histologically proven carcinoma (10 lung, 9 breast, 1 cervical, 1 bladder), and 3 had an intrathoracic imaging abnormality. Cancer anteceded neurological symptoms in 4 of 28 patients. Cancer detection frequency increased with continued surveillance. Neurological disorders, in decreasing frequency, were brainstem syndrome (including opsoclonus, myoclonus, or both), cerebellar syndrome, myelopathy, peripheral neuropathy, cranial neuropathy, movement disorder, encephalopathy, Lambert–Eaton syndrome, and seizures. Four patients had laryngospasm and four had jaw opening dystonia (two with neck dystonia). Nine (32%) were wheelchair‐bound 1 month after neurological symptom onset. Most improved neurologically after immunomodulatory or tumor‐directed therapy. Accompanying autoantibodies, found in 73% of sera, included ANNA‐1, ANNA‐3, CRMP‐5‐IgG, P/Q‐type and N‐type Ca 2+ channel antibodies, and muscle‐type acetylcholine receptor antibody. Some neurological accompaniments of ANNA‐2 may reflect potentially pathogenic humoral or cell‐mediated responses to coimmunogenic tumor antigens, for example, Lambert–Eaton syndrome (P/Q‐type Ca 2+ channel antibody) and peripheral neuropathy (ANNA‐1 effector T cells). Ann Neurol 2003
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dalmau, J., Graus, F., Rosenblum, M. K., & Posner, J. B. (1992) · MEDICINE · doi:10.1097/00005792-199203000-00001 · Cited by 819
Lucchinetti, C. F., Kimmel, D. W., & Lennon, V. A. (1998) · Neurology · doi:10.1212/wnl.50.3.652 · Cited by 499
Self-citationCytotoxic T lymphocytes in autoimmune and degenerative CNS diseases
Neumann, H. (2002) · Trends in Neurosciences · doi:10.1016/s0166-2236(02)02154-9 · Cited by 480
Tumor-specific killer cells in paraneoplastic cerebellar degeneration
Albert, M. L., Darnell, J. C., Bender, A., Francisco, L. M., Bhardwaj, N., & Darnell, R. B. (1998) · Nature Medicine · doi:10.1038/3315 · Cited by 449
Anti‐Ri: An antibody associated with paraneoplastic opsoclonus and breast cancer
Luque, F. A., Furneaux, H. M., Ferziger, R., Rosenblum, M. K., Wray, S. H., Schold, S. C., Glantz, M. J., Jaeckle, K. A., Biran, H., Lesser, M., et al. (1991) · Annals of Neurology · doi:10.1002/ana.410290303 · Cited by 402
Protein degradation and the generation of MHC class I-presented peptides
Rock, K. L., York, I. A., Saric, T., & Goldberg, A. L. (2002) · Advances in Immunology · doi:10.1016/s0065-2776(02)80012-8 · Cited by 339
Buckanovich, R. J., Posner, J. B., & Darnell, R. B. (1993) · Neuron · doi:10.1016/0896-6273(93)90077-5 · Cited by 319
Molecular and clinical diversity in paraneoplastic immunity to Ma proteins
Rosenfeld, M. R., Eichen, J. G., Wade, D. F., Posner, J. B., & Dalmau, J. (2001) · Annals of Neurology · doi:10.1002/ana.1288 · Cited by 291
Vernino, S., Adamski, J., Kryzer, T. J., Fealey, R. D., & Lennon, V. A. (1998) · Neurology · doi:10.1212/wnl.50.6.1806 · Cited by 226
Self-citationYang, Y. Y. L., Yin, G. L., & Darnell, R. B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13254 · Cited by 219
Cited by
Recommended diagnostic criteria for paraneoplastic neurological syndromes
Graus, F. (2004) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.034447 · Cited by 1,610
Paraneoplastic Syndromes Involving the Nervous System
Darnell, R. B., & Posner, J. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmra023009 · Cited by 1,062
Paraneoplastic syndromes of the CNS
Dalmau, J., & Rosenfeld, M. R. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70060-7 · Cited by 873
Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes
Graus, F., Vogrig, A., Muñiz-Castrillo, S., Antoine, J.-C. G., Desestret, V., Dubey, D., Giometto, B., Irani, S. R., Joubert, B., Leypoldt, F., et al. (2021) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000001014 · Cited by 759
Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy: A Novel Meningoencephalomyelitis
Fang, B., McKeon, A., Hinson, S. R., Kryzer, T. J., Pittock, S. J., Aksamit, A. J., & Lennon, V. A. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2016.2549 · Cited by 568
Self-citation
Metadata
- Authors
- Pittock, S. J., Lucchinetti, C. F., & Lennon, V. A.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2003-03-06
- Volume
- 53
- Issue
- 5
- Pages
- 580-587
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2068359998
- Cited by
- 331
- References
- 22
- FWCI
- 7.46
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Anti‐neuronal nuclear autoantibody type 2: Paraneoplastic accompaniments. https://app.cochat.ai/papers/10.1002/ana.10518
- The paper
- Pittock, S. J., Lucchinetti, C. F., & Lennon, V. A. (2003). Anti‐neuronal nuclear autoantibody type 2: Paraneoplastic accompaniments. Annals of Neurology. https://doi.org/10.1002/ana.10518
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.